Extension of Exclusivity

Flovent, Arnuity Ellipta, Ventolin Inhalers Patents Antitrust Class Action

When patents for name-brand drugs expire and generic versions are allowed to enter the market, drug prices fall for consumers. But this class action alleges that GlaxoSmithKline, PLC (GSK) has managed to keeps its exclusivity and high prices with schemes to avoid competition for its inhalers. The complaint claims that the company has managed to  Read more